?
0000-0002-9820-2078 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (504)
- Targeting the gut–brain axis with Bifidobacterium breve in neurodegeneration: A comprehensive narrative review of current evidence in Alzheimer's disease and cognitive aging Save
- From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease Save
- Glucose oxidase-powered nanocatalytic medicine: Rewiring tumor metabolism for multimodal cancer therapy Save
- Telomerase dynamics in stem cells: Unraveling the molecular nexus of cellular aging and regeneration Save
- Curcumin–Piperine Self-Nanoemulsifying Delivery in Zanthoxylum rhetsa Seed Oil Attenuates Cuprizone-Induced Frontal Cortex Toxicity Save
- An Update of Fungal Endophyte Diversity and Strategies for Augmenting Therapeutic Potential of their Potent Metabolites: Recent Advancement Save
- Epidemiology of neuropsychiatric complications in HIV Save
- Evaluation of the Sporadic Anti-Alzheimer's Activity of Purpurin Using In Silico, In Vitro, and In Vivo Approaches Save
- Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseases Save
- Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease Save
- Black Seed Oil-Based Curcumin Nanoformulations Ameliorated Cuprizone-Induced Demyelination in the Mouse Hippocampus Save
- Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine Save
- Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation Save
- Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases Save
- Glymphotherapeutics for Alzheimer's disease: Time to move the needle Save
- Naringenin as a potent inhibitor molecule for targeting microtubule affinity-regulating kinase 4 (mark4): a molecular docking and in vitro study for therapeutics of Alzheimer's disease Save
- Natural products in the management of neurodegenerative diseases Save
- Navigating the Maze of Alzheimer's disease by exploring BACE1: Discovery, current scenario, and future prospects Save
- Phytoconstituents as potential therapeutic agents against COVID-19: a computational study on inhibition of SARS-CoV-2 main protease Save
- Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies Save